Subhashaan Sreedharan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Subhashaan Sreedharan has a total of 92 co-authors. Here are the top co-authors by number of shared publications:
Mustafa Mian
Department of Oral and Maxillofacial Surgery Royal Melbourne Hospital Parkville Victoria Australia
8 shared publicationsAlexander Rhodes
Melbourne Medical School, University of Melbourne, Melbourne, VIC, 3010, Australia; Department of Radiology, Royal Melbourne Hospital, Melbourne VIC, 3010, Australia
2 shared publicationsDavid John Tobias McArdle
Department of Radiology Royal Melbourne Hospital Parkville Victoria Australia
2 shared publications- Jianbin Liu
Department of Radiology and
2 shared publications - Jinrong Wu
Research Centre for Data Analytics and Cognition, La Trobe University, Bundoora, VIC 3086, Australia
2 shared publications - Lei Zhang
Northwestern Polytechnical University, Xi'an, China
2 shared publications
Latest Publications
- Open Access
- 5 November 2026
- Published by Springer Nature in European Radiology
- p. 1-10
Saline tract sealing to reduce pneumothorax rates following CT-guided percutaneous lung biopsy: a systematic review and meta-analysis
Objectives: Pneumothorax remains the most common complication following CT-guided percutaneous lung biopsy, increasing morbidity and healthcare utilisation. Saline tract sealing has been proposed as a simple technique to reduce the risk of pneumothorax, but its effectiveness remains unclear. Materials and methods: A systematic review and meta-analysis were performed according to PRISMA guidelines. PubMed, Embase, and CENTRAL were searched for studies evaluating saline tract sealing following CT-guided percutaneous lung biopsy. Pooled risk ratios (RRs) with 95% confidence intervals (CIs) were calculated using a random-effects model for pneumothorax and chest drain insertion. Results: The search identified 151 articles, of which 11 studies met the inclusion criteria. Ten studies (one randomised controlled trial and nine observational studies) comprising 2252 patients compared saline tract sealing with no sealant and were included in the meta-analysis. One study used an alternative sealant comparator and was synthesised narratively. Saline tract sealing was associated with a significant reduction in pneumothorax (RR 0.58, 95% CI: 0.42–0.80; I ² = 82%) and chest drain insertion (RR 0.30, 95% CI: 0.15–0.61; I ² = 55%). These findings remained robust on sensitivity analysis excluding studies incorporating rapid patient rollover as a co-intervention, with persistent reductions in pneumothorax (RR 0.51, 95% CI: 0.33–0.78) and chest drain insertion (RR 0.31, 95% CI: 0.13–0.75). Conclusion: Saline tract sealing may be an effective and practical strategy to reduce the incidence of pneumothorax and chest drain insertion after CT-guided percutaneous lung biopsy. Given the very low certainty of the current evidence, further randomised controlled trials are required to confirm these findings. Key Points: Question Does saline tract sealing reduce rates of pneumothorax and chest drain insertion following CT-guided percutaneous lung biopsy? Findings Saline tract sealant was associated with reduced rates of pneumothorax and chest drain insertion following CT-guided percutaneous lung biopsy compared with no sealant . Clinical relevance Saline tract sealing is a simple, low-cost technique that can be readily implemented to improve the safety of CT-guided percutaneous lung biopsy .
- 5 November 2026
- Published by Springer Nature in European Radiology
- p. 1-10
Open AccessSaline tract sealing to reduce pneumothorax rates following CT-guided percutaneous lung biopsy: a systematic review and meta-analysis
Objectives: Pneumothorax remains the most common complication following CT-guided percutaneous lung biopsy, increasing morbidity and healthcare utilisation. Saline tract sealing has been proposed as a simple technique to reduce the risk of pneumothorax, but its effectiveness remains unclear. Materials and methods: A systematic review and meta-analysis were performed according to PRISMA guidelines. PubMed, Embase, and CENTRAL were searched for studies evaluating saline tract sealing following CT-guided percutaneous lung biopsy. Pooled risk ratios (RRs) with 95% confidence intervals (CIs) were calculated using a random-effects model for pneumothorax and chest drain insertion. Results: The search identified 151 articles, of which 11 studies met the inclusion criteria. Ten studies (one randomised controlled trial and nine observational studies) comprising 2252 patients compared saline tract sealing with no sealant and were included in the meta-analysis. One study used an alternative sealant comparator and was synthesised narratively. Saline tract sealing was associated with a significant reduction in pneumothorax (RR 0.58, 95% CI: 0.42–0.80; I ² = 82%) and chest drain insertion (RR 0.30, 95% CI: 0.15–0.61; I ² = 55%). These findings remained robust on sensitivity analysis excluding studies incorporating rapid patient rollover as a co-intervention, with persistent reductions in pneumothorax (RR 0.51, 95% CI: 0.33–0.78) and chest drain insertion (RR 0.31, 95% CI: 0.13–0.75). Conclusion: Saline tract sealing may be an effective and practical strategy to reduce the incidence of pneumothorax and chest drain insertion after CT-guided percutaneous lung biopsy. Given the very low certainty of the current evidence, further randomised controlled trials are required to confirm these findings. Key Points: Question Does saline tract sealing reduce rates of pneumothorax and chest drain insertion following CT-guided percutaneous lung biopsy? Findings Saline tract sealant was associated with reduced rates of pneumothorax and chest drain insertion following CT-guided percutaneous lung biopsy compared with no sealant . Clinical relevance Saline tract sealing is a simple, low-cost technique that can be readily implemented to improve the safety of CT-guided percutaneous lung biopsy .
- 5 October 2023
- Published by Wiley in Journal of Medical Imaging and Radiation Oncology
- Vol. 68 (1) , 50-56
Rising use of diagnostic imaging in Australia: An analysis of Medicare‐funded radiology services between 2000 and 2021
Introduction: The use of diagnostic imaging services is increasing worldwide. This has important impacts on healthcare resource allocation and potential risks to the population. This study aimed to quantify trends in medical imaging in Australia over the past two decades.Methods: Data were extracted from the Australian Medicare Benefits Schedule (MBS) between 2000 and 2021. Simple linear regression analyses were performed to assess changes in absolute utilisation and utilisation rate per 100,000 population of total imaging services as well as by each imaging modality. Logistic regression analysis was performed to assess changes in total imaging services as a proportion of total Medicare services over time. Chi‐squared test was used to assess for change in modality composition of imaging services.Results: There were 436,255,500 imaging studies performed between 2000 and 2021. The absolute utilisation of total imaging services increased annually by an average of 864,404 (95% CI: 808,235–920,573, p < 0.001). For each consecutive year, the proportion of total Medicare services attributed to total imaging services increased by 0.01% (95% CI: 0.01–0.01, p < 0.01). There was also a statistically significant increase in the utilisation rates of imaging services per 100,000 population for each imaging modality. The number of imaging services per radiologist increased on average by 74 (95% CI: 26–122, p < 0.05) annually.Conclusion: The utilisation of diagnostic imaging services has increased in Australia between 2000 and 2021, outpacing the population growth, total healthcare services, and the radiologist workforce.
- 5 October 2023
- Published by Wiley in Journal of Medical Imaging and Radiation Oncology
- Vol. 68 (1) , 50-56
Rising use of diagnostic imaging in Australia: An analysis of Medicare‐funded radiology services between 2000 and 2021
Introduction: The use of diagnostic imaging services is increasing worldwide. This has important impacts on healthcare resource allocation and potential risks to the population. This study aimed to quantify trends in medical imaging in Australia over the past two decades.Methods: Data were extracted from the Australian Medicare Benefits Schedule (MBS) between 2000 and 2021. Simple linear regression analyses were performed to assess changes in absolute utilisation and utilisation rate per 100,000 population of total imaging services as well as by each imaging modality. Logistic regression analysis was performed to assess changes in total imaging services as a proportion of total Medicare services over time. Chi‐squared test was used to assess for change in modality composition of imaging services.Results: There were 436,255,500 imaging studies performed between 2000 and 2021. The absolute utilisation of total imaging services increased annually by an average of 864,404 (95% CI: 808,235–920,573, p < 0.001). For each consecutive year, the proportion of total Medicare services attributed to total imaging services increased by 0.01% (95% CI: 0.01–0.01, p < 0.01). There was also a statistically significant increase in the utilisation rates of imaging services per 100,000 population for each imaging modality. The number of imaging services per radiologist increased on average by 74 (95% CI: 26–122, p < 0.05) annually.Conclusion: The utilisation of diagnostic imaging services has increased in Australia between 2000 and 2021, outpacing the population growth, total healthcare services, and the radiologist workforce.
- 14 February 2023
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 81 (5) , 583-592
Oral and Maxillofacial Injuries Associated With E-Cigarette Explosions: A Systematic Review and Management Guidelines Proposal
- 14 February 2023
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 81 (5) , 583-592
Oral and Maxillofacial Injuries Associated With E-Cigarette Explosions: A Systematic Review and Management Guidelines Proposal
- Open Access
- 29 September 2022
- Published by Australian Society of Plastic Surgeons in Australasian Journal of Plastic Surgery
- Vol. 5 (2) , 54-59
The impact of the COVID-19 pandemic on management of cutaneous malignancies in Australia
**Introduction**: The Australian healthcare system, including its management of cutaneous malignancies, has faced unprecedented challenges due to the COVID-19 pandemic. This study aimed to quantify the impact of the first wave of the pandemic on the diagnoses and management of cutaneous malignancies in Australia.**Methods**: Monthly service data was extracted from the Australian Medicare Benefits Schedule database for all cutaneous biopsies, non-melanotic skin cancer (NMSC) excisions and melanoma excisions performed between January 2017 and December 2019. Holt-Winters exponential smoothing forecasting models were developed for total biopsies, NMSC excisions and melanoma excisions. These models were used to predict monthly data between January 2020 and June 2020 with a 95 per cent confidence interval (p < 0.05). Absolute and percentage residual differences (RDs) between actual and predicted excisions for this time period were calculated.**Results**: There were statistically significant reductions in total NMSC excisions in March 2020 (RD: −6,943, −13.0%), April 2020 (RD: −8,954, −12.2%), May 2020 (RD: −17,667, −20.9%) and June 2020 (RD: −5,152, −6.9%). There were statistically significant reductions in melanoma excisions in April 2020 (RD: –695, –11.1%), May 2020 (RD: −1,982, –28.7%) and June 2020 (RD: –973, –16.0%).**Conclusions**: There was a significant reduction in skin cancer excisions in Australia during the COVID-19 pandemic. This observed reduction in skin cancer surgery has significant public health implications, highlighting the need for improved surveillance, diagnoses and increased treatment capacity of cutaneous malignancies during the recovery phase of the pandemic.
- 29 September 2022
- Published by Australian Society of Plastic Surgeons in Australasian Journal of Plastic Surgery
- Vol. 5 (2) , 54-59
Open AccessThe impact of the COVID-19 pandemic on management of cutaneous malignancies in Australia
**Introduction**: The Australian healthcare system, including its management of cutaneous malignancies, has faced unprecedented challenges due to the COVID-19 pandemic. This study aimed to quantify the impact of the first wave of the pandemic on the diagnoses and management of cutaneous malignancies in Australia.**Methods**: Monthly service data was extracted from the Australian Medicare Benefits Schedule database for all cutaneous biopsies, non-melanotic skin cancer (NMSC) excisions and melanoma excisions performed between January 2017 and December 2019. Holt-Winters exponential smoothing forecasting models were developed for total biopsies, NMSC excisions and melanoma excisions. These models were used to predict monthly data between January 2020 and June 2020 with a 95 per cent confidence interval (p < 0.05). Absolute and percentage residual differences (RDs) between actual and predicted excisions for this time period were calculated.**Results**: There were statistically significant reductions in total NMSC excisions in March 2020 (RD: −6,943, −13.0%), April 2020 (RD: −8,954, −12.2%), May 2020 (RD: −17,667, −20.9%) and June 2020 (RD: −5,152, −6.9%). There were statistically significant reductions in melanoma excisions in April 2020 (RD: –695, –11.1%), May 2020 (RD: −1,982, –28.7%) and June 2020 (RD: –973, –16.0%).**Conclusions**: There was a significant reduction in skin cancer excisions in Australia during the COVID-19 pandemic. This observed reduction in skin cancer surgery has significant public health implications, highlighting the need for improved surveillance, diagnoses and increased treatment capacity of cutaneous malignancies during the recovery phase of the pandemic.
- 1 August 2022
- Published by Wiley in Anz Journal of Surgery
- Vol. 93 (3) , 727-729
Intraoperative fluorescence imaging using indocyanine green to assess the lymphatic drainage of a small bowel adenocarcinoma
- 1 August 2022
- Published by Wiley in Anz Journal of Surgery
- Vol. 93 (3) , 727-729
Intraoperative fluorescence imaging using indocyanine green to assess the lymphatic drainage of a small bowel adenocarcinoma
- 1 September 2021
- Published by Elsevier in Heart & Lung
- Vol. 50 (5) , 736-741
Radiological findings of e-cigarette or vaping product use associated lung injury: A systematic review
- 1 September 2021
- Published by Elsevier in Heart & Lung
- Vol. 50 (5) , 736-741
Radiological findings of e-cigarette or vaping product use associated lung injury: A systematic review
- 20 July 2021
- Published by Wiley in Journal of Medical Imaging and Radiation Oncology
- Vol. 66 (3) , 377-384
The impact of the COVID‐19 pandemic on diagnostic imaging services in Australia
Introduction: The COVID‐19 pandemic is driving unprecedented changes in healthcare services worldwide. This study aimed to quantify the impact of the first wave of the COVID‐19 pandemic on diagnostic imaging services in Australia using an interrupted time series model.Methods: Monthly data were extracted from the Australian Medicare Benefits Schedule for all diagnostic imaging services performed between January 2016 and December 2019. Holt‐Winters forecasting models were developed for total imaging services as well as for each imaging modality. The models were used to predict monthly data between January 2020 and June 2020 with a 95% confidence interval (P < 0.05). Absolute and percentage residual differences (RD) between observed and predicted services for this time period were calculated.Results: There were statistically significant reductions in total imaging services performed in March 2020 (RD: −332260, −13.1%, 95% CI: −17.5% to −8.4%), April 2020 (RD: −716957, −32.4%, 95% CI: −36.2% to −28.1%) and May 2020 (RD: −571634, −21.4%, 95% CI: −25.1% to −17.3%). Nuclear medicine and CT services were relatively less impacted than general radiography, ultrasound, and MRI services. There was also a statistically significant increase in nuclear medicine and CT services performed in June 2020 compared to predicted values.Conclusions: During the first wave of COVID‐19 in Australia, there was a significant reduction in total diagnostic imaging services, with variable impacts on different imaging modalities. These findings may have significant public health implications and can be used to inform evidence‐based strategies in the recovery phase of the pandemic.
- 20 July 2021
- Published by Wiley in Journal of Medical Imaging and Radiation Oncology
- Vol. 66 (3) , 377-384
The impact of the COVID‐19 pandemic on diagnostic imaging services in Australia
Introduction: The COVID‐19 pandemic is driving unprecedented changes in healthcare services worldwide. This study aimed to quantify the impact of the first wave of the COVID‐19 pandemic on diagnostic imaging services in Australia using an interrupted time series model.Methods: Monthly data were extracted from the Australian Medicare Benefits Schedule for all diagnostic imaging services performed between January 2016 and December 2019. Holt‐Winters forecasting models were developed for total imaging services as well as for each imaging modality. The models were used to predict monthly data between January 2020 and June 2020 with a 95% confidence interval (P < 0.05). Absolute and percentage residual differences (RD) between observed and predicted services for this time period were calculated.Results: There were statistically significant reductions in total imaging services performed in March 2020 (RD: −332260, −13.1%, 95% CI: −17.5% to −8.4%), April 2020 (RD: −716957, −32.4%, 95% CI: −36.2% to −28.1%) and May 2020 (RD: −571634, −21.4%, 95% CI: −25.1% to −17.3%). Nuclear medicine and CT services were relatively less impacted than general radiography, ultrasound, and MRI services. There was also a statistically significant increase in nuclear medicine and CT services performed in June 2020 compared to predicted values.Conclusions: During the first wave of COVID‐19 in Australia, there was a significant reduction in total diagnostic imaging services, with variable impacts on different imaging modalities. These findings may have significant public health implications and can be used to inform evidence‐based strategies in the recovery phase of the pandemic.
- Open Access
- 19 April 2021
- Published by SAGE Publications in Asia Pacific Journal of Public Health
- Vol. 33 (5) , 595-597
The Impact of COVID-19 on First Nations People Health Assessments in Australia
The COVID-19 (coronavirus disease 2019) pandemic has the potential to worsen existing health inequalities faced by Aboriginal and Torres Strait Islander peoples in Australia. We aimed to assess the impact of the pandemic on First Nations people health assessments using an interrupted time series model utilizing data extracted from the Australian Medicare Benefits Schedule database. Additive triple exponential smoothing was used to model health assessments undertaken between January 2017 and December 2019. The model was used to predict health assessments between January 2020 and June 2020 with 95% confidence (P < .05). There was no significant difference between observed and predicted First Nations people health assessments in January, February, and June 2020. However, we found a statistically significant decrease in health assessments in March (16.5%), April (23.1%), and May (17.2%) 2020. The proportion of total health assessments delivered via telehealth was 0.5%, 23.6%, 17.6%, and 10.0% for March, April, May, and June 2020, respectively. The decrease in total First Nations people health assessments compounds the risk of poorer health outcomes in this population already vulnerable due to a high burden of chronic disease and considerable social, economic, and health inequalities. Strategies to improve the delivery of telehealth for First Nations people must be considered.
- 19 April 2021
- Published by SAGE Publications in Asia Pacific Journal of Public Health
- Vol. 33 (5) , 595-597
Open AccessThe Impact of COVID-19 on First Nations People Health Assessments in Australia
The COVID-19 (coronavirus disease 2019) pandemic has the potential to worsen existing health inequalities faced by Aboriginal and Torres Strait Islander peoples in Australia. We aimed to assess the impact of the pandemic on First Nations people health assessments using an interrupted time series model utilizing data extracted from the Australian Medicare Benefits Schedule database. Additive triple exponential smoothing was used to model health assessments undertaken between January 2017 and December 2019. The model was used to predict health assessments between January 2020 and June 2020 with 95% confidence (P < .05). There was no significant difference between observed and predicted First Nations people health assessments in January, February, and June 2020. However, we found a statistically significant decrease in health assessments in March (16.5%), April (23.1%), and May (17.2%) 2020. The proportion of total health assessments delivered via telehealth was 0.5%, 23.6%, 17.6%, and 10.0% for March, April, May, and June 2020, respectively. The decrease in total First Nations people health assessments compounds the risk of poorer health outcomes in this population already vulnerable due to a high burden of chronic disease and considerable social, economic, and health inequalities. Strategies to improve the delivery of telehealth for First Nations people must be considered.